Medical News

RSS

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.

20 Jun 2011

IsoRay announces combination therapy study for prostate cancer

IsoRay Inc., announced today a new dual therapy study using Cesium-131 brachytherapy (internal radiation therapy) and external beam radiation. Multiple sites have now received Institutional Review Board (IRB) approval for this study which will examine the efficacy of combining intensity modulated radiation (IMRT) with Cesium-131 brachytherapy to treat intermediate and high risk early stage prostate cancer.

20 Jun 2011

CarePoint acquires infusion business of ArTex Medical

Waud Capital Partners announced that its portfolio company, CarePoint Partners, has acquired the infusion business of ArTex Medical, Inc., marking its 13th acquisition in under four years.

20 Jun 2011

Bruker launches Hyperspectral Imaging System for detection of gases

Following Bruker's acquisition of Sigma ElectroOptics in December 2010, Bruker is now launching its expanded product line for the remote infrared detection of gases in industrial, environmental and homeland security applications.

20 Jun 2011

First Edition: June 20, 2011

Today's headlines include reports about new trends in the health care marketplace, including efforts to help seniors live at home longer and why some consumers may face bigger bills for out-of-network care.

20 Jun 2011

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Boston Scientific Corporation today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.

20 Jun 2011

DATATRAK expands and rebrands unified software suite

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the expansion and rebranding of their unified software suite as DATATRAK ONE.

20 Jun 2011

SAIC receives USAMRMC contract to provide CDMRP with scientific services

Science Applications International Corporation announced today it was awarded a follow-on contract by the U.S. Army Medical Research and Materiel Command (USAMRMC) to provide scientific and other support services to the Congressionally Directed Medical Research Programs.

20 Jun 2011

Teleflex, Amerinet sign deal for VasoNova Vascular Positioning System

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.

20 Jun 2011

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.

20 Jun 2011

WellAWARE Systems announces new partnership with Masonic Homes of Kentucky

WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced a new partnership with Masonic Homes of Kentucky.

20 Jun 2011

Neovasc first quarter revenues increase 10% to $1,169,920

Neovasc Inc., today announced financial results for the three months ended March 31, 2011 and advances in its product development programs.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Standard Life's new plan offers financial protection from uncovered medical expenses

New to the Standard Life and Accident Insurance Company (Standard Life) portfolio is a Critical Illness product for both individual and worksite markets.

20 Jun 2011

Perceptive's Clinical Trial Management System now available as SaaS application

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that its Clinical Trial Management System is available as an on-demand, software-as-a-service (SaaS) application.

From Parexel 20 Jun 2011

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert Pharmaceuticals, Inc. announced today the advancement of two programs from its DCE Platform. CTP-499 is progressing into Phase 2 clinical trials for diabetic nephropathy and C-21191 has been selected as a lead candidate for spasticity.

20 Jun 2011

Project to explore how interactivity, music can improve health outcomes of children with disabilities

Norwegian researchers will explore how a cross between intelligent furniture and toys can encourage children with disabilities to become more active.

20 Jun 2011

AARP, Philadelphia Department of Recreation to host outdoor Health and Wellness event

AARP and the Philadelphia Department of Recreation will be hosting an outdoor Health and Wellness event on Monday June 20, 2011 from 12:00 pm- 2:00 pm at Love Park in Center City Philadelphia.

20 Jun 2011

Premier healthcare honors Toshiba with Supplier Performance Award

Toshiba America Medical Systems, Inc. today announced that it is a winner of the sixth annual Performance Award, presented by the Premier healthcare alliance.

20 Jun 2011

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo Pharmaceuticals, of Chadds Ford, Pa, U.S.A., announced today that they have achieved a late stage discovery milestone in their joint program focused on cancer.

20 Jun 2011